Sylvia Wojczewski, a member of BIO Deutschland’s board and managing director of BioSpring GmbH, accompanied a delegation to China headed by German Chancellor Angela Merkel.
Peter Heinrich, chairman of the board of BIO Deutschland, hosted a visit by the Beijing-based CR Life Science Group at the premises of BioM’s Munich Biotech Cluster.
The continuation of the Pharma Dialogue has involved competence teams working on various thematic areas. Competence Team III is focusing on technologies and trends. In the Team’s May meeting, the Federal Institute for Drugs and Medical Devices (BfArM) gave a report on translational medicine.